If you believe artificial intelligence will take up a growing share of energy, Vistra might just be the stock for you.

Vistra's forward EBITDA growth is strong, justifying a higher forward EV/EBITDA. Read why VST stock has the potential for ...

WILMINGTON, DE — Incyte (Nasdaq: INCY) announced that the U.S. Food and Drug Administration has approved Opzelura (ruxolitinib) cream 1.5% for children as young as two with mild to moderate ...